ELECTROCORE INC

ECORNASDAQ

🏆 #3263 by market capEarnings Nov 4US Equity

$9.12▲ $0.16 (+1.79%)

🌙 After hours$9.12▲ 0.00%Regular close · extended-hours price shown

1h—

24h▲ 1.8%

7d▲ 41.6%

14d▲ 47.2%

30d▲ 40.3%

1y▲ 102.7%

🏦Market Cap

$82M

Small Cap

📈Revenue Growth (YoY)

+31.9%

High Growth

📊Gross Margin

87.7%

High

💵FCF Margin

—

⚖️P/S Ratio

2.2x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $9.02 – $9.28
52-Week Range: $4.16 – $10.50
Volume: $6.37B
Avg Volume: $4.46B
Shares Outstanding: 9.0M
Next Earnings: Sep 13, 2026

Fundamentals Snapshot

Annual Revenue: $32M
Last Q Revenue: $9M
P/E Ratio: —
P/S Ratio: 2.2x
EPS (TTM): $-1.78
Dividend Yield: —

Why Investors Own ECOR

✓High-growth profile — revenue up +59.4% YoY with expanding US Equity exposure.
✓Healthy economics — 45% gross margin and 28% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$32M▲ +62.0% YoY

Gross Margin (TTM)

45.0%▲ +0.3% YoY

Operating Income (TTM)

$3M▲ +62.0% YoY

Free Cash Flow (TTM)

$9M▲ +62.0% YoY

About ELECTROCORE INC

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

🦦